157 related articles for article (PubMed ID: 35478448)
1. Identification of B-cell dominant epitopes in the recombinant protein P29 from Echinococcus granulosus.
Lv Y; Li S; Zhang T; Zhu Y; Tao J; Yang J; Chang L; Wu C; Zhao W
Immun Inflamm Dis; 2022 May; 10(5):e611. PubMed ID: 35478448
[TBL] [Abstract][Full Text] [Related]
2. Identification of a dominant murine T-cell epitope in recombinant protein P29 from Echinococcus granulosus.
Lv Y; Zhu Y; Chang L; Yang J; Zhao Y; Zhao J; Wang Y; Zhu M; Wu C; Zhao W
Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):482-493. PubMed ID: 35607954
[TBL] [Abstract][Full Text] [Related]
3. lncRNA028466 regulates Th1/Th2 cytokine expression and associates with Echinococcus granulosus antigen P29 immunity.
Wang C; Yang SH; Niu N; Tao J; Du XC; Yang JH; Zhu MX; Wang YN; Zhao W
Parasit Vectors; 2021 Jun; 14(1):295. PubMed ID: 34082780
[TBL] [Abstract][Full Text] [Related]
4. Immunoprotection of recombinant Eg.P29 against Echinococcus granulosus in sheep.
Wang H; Li Z; Gao F; Zhao J; Zhu M; He X; Niu N; Zhao W
Vet Res Commun; 2016 Jun; 40(2):73-9. PubMed ID: 27094043
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of peptide-based vaccine composed of epitopes from Echinococcus granulosus rEg.P29.
Lv Y; Chang L; Yang J; Wen J; Zhao Y; Zhu M; Wu C; Zhao W
FASEB J; 2023 Apr; 37(4):e22819. PubMed ID: 36848174
[TBL] [Abstract][Full Text] [Related]
6. Recombinant antigen P29 of
Yang J; Zhao Y; Fu Y; Lv Y; Zhu Y; Zhu M; Zhao J; Wang Y; Wu C; Zhao W
Front Immunol; 2023; 14():1243204. PubMed ID: 38187382
[No Abstract] [Full Text] [Related]
7. Clinical characteristics and antibodies against Echinococcus granulosus recombinant antigen P29 in patients with cystic echinococcosis in China.
Tao J; Du X; Liu K; Wang C; Lv Y; Wang M; Yang Z; Yang J; Li S; Wu C; Li M; Zhao W
BMC Infect Dis; 2022 Jul; 22(1):609. PubMed ID: 35820830
[TBL] [Abstract][Full Text] [Related]
8. Changes in intestinal flora of mice induced by rEg.P29 epitope peptide vaccines.
Zhang T; Lv Y; Zhao Y; Yang J; Qian B; Zhu Y; Zhao W; Zhu M
Immun Inflamm Dis; 2023 Nov; 11(11):e1082. PubMed ID: 38018604
[TBL] [Abstract][Full Text] [Related]
9. MiR-374b-5p Regulates T Cell Differentiation and Is Associated with rEg.P29 Immunity.
Li D; Du X; Zhu M; Yang S; Zhao W
Biomed Res Int; 2020; 2020():8024763. PubMed ID: 32908913
[No Abstract] [Full Text] [Related]
10. The Recombinant
Du X; Zhu M; Zhang T; Wang C; Tao J; Yang S; Zhu Y; Zhao W
Front Immunol; 2022; 13():773276. PubMed ID: 35211114
[No Abstract] [Full Text] [Related]
11. Immunoprotective effect and mechanism of rEg.P29 against CD4
Li M; Zhu Y; Li Z; Song J; Zhao W
Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):482-489. PubMed ID: 38151996
[TBL] [Abstract][Full Text] [Related]
12. Preliminary Evaluation of Recombinant EPC1 and TPx for Serological Diagnosis of Animal Cystic Echinococcosis.
Liang Y; Song H; Wu M; Xie Y; Gu X; He R; Lai W; Jing B; Peng X; Yang G
Front Cell Infect Microbiol; 2020; 10():177. PubMed ID: 32426296
[TBL] [Abstract][Full Text] [Related]
13. Echinococcus P29 antigen: molecular characterization and implication on post-surgery follow-up of CE patients infected with different species of the Echinococcus granulosus complex.
Boubaker G; Gottstein B; Hemphill A; Babba H; Spiliotis M
PLoS One; 2014; 9(5):e98357. PubMed ID: 24851904
[TBL] [Abstract][Full Text] [Related]
14. Activity in mice of recombinant BCG-EgG1Y162 vaccine for Echinococcus granulosus infection.
Ma X; Zhao H; Zhang F; Zhu Y; Peng S; Ma H; Cao C; Xin Y; Yimiti D; Wen H; Ding J
Hum Vaccin Immunother; 2016; 12(1):170-5. PubMed ID: 26266551
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of EgA31 and EgG1Y162 proteins for designing a multi-epitope vaccine against Echinococcus granulosus.
Zhao X; Zhang F; Li Z; Wang H; An M; Li Y; Pang N; Ding J
Infect Genet Evol; 2019 Sep; 73():98-108. PubMed ID: 31022474
[TBL] [Abstract][Full Text] [Related]
16. [Cloning, Expression and Immungenicity Analysis of Antigen Eg-01883 Screened from Protoscoleces of Echinococcus granulosus].
Zhao YQ; Li ZH; Wang H; Zhu MX; Niu N; Wang YN; Zhao JQ; Li N; Tong XQ; Song JH; Zhao W
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2016 Jun; 34(3):208-13. PubMed ID: 30129713
[TBL] [Abstract][Full Text] [Related]
17. Immunization of mice with egG1Y162-1/2 provides protection against Echinococcus granulosus infection in BALB/c mice.
Zhang F; Li S; Zhu Y; Zhang C; Li Y; Ma H; Pang N; An M; Wang H; Ding J
Mol Immunol; 2018 Feb; 94():183-189. PubMed ID: 29328998
[TBL] [Abstract][Full Text] [Related]
18. Reverse vaccinology approach identify an Echinococcus granulosus tegumental membrane protein enolase as vaccine candidate.
Gan W; Zhao G; Xu H; Wu W; Du W; Huang J; Yu X; Hu X
Parasitol Res; 2010 Mar; 106(4):873-82. PubMed ID: 20127115
[TBL] [Abstract][Full Text] [Related]
19. Echinococcus granulosus: immunoprotection accompanyied by humoral and cytokine response against secondary hydatidosis in mice immunized with rEg.myophilin.
Sun J; Wang Y; Li Z; Ma R; Ji H; Xiong Y; Wang Y; Li Z; Zhao W
Vet Res Commun; 2011 Apr; 35(4):193-200. PubMed ID: 21336572
[TBL] [Abstract][Full Text] [Related]
20. Identification and diagnostic value of a major antibody epitope on the 12 kDa antigen from Echinococcus granulosus (hydatid disease) cyst fluid.
Leggatt GR; McManus DP
Parasite Immunol; 1994 Feb; 16(2):87-96. PubMed ID: 7517028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
